![](/img/cover-not-exists.png)
P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy
Gridelli, C., Reck, M., Gregorc, V., Migliorino, M., Muller, T., Manegold, C., Favaretto, A., Schmittel, A., Caffo, O., Blatter, J., Munoz, M., Crucitta, E., Rossi, A., Koschel, G.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80981-x
Date:
July, 2005
File:
PDF, 140 KB
english, 2005